KSPEN
KSSMN
ASSMN
Articles
- Page Path
- HOME > Ann Clin Nutr Metab > Volume 15(1); 2023 > Article
- Review Selenium deficiency and supplementation in infants: a narrative review
-
Ji Young Lee1
, Min Jung Kang1,2, Hyun Jeong Kim1, Sung Yun Suh1, Yoon Sook Cho1, Sook Hee An3 -
Annals of Clinical Nutrition and Metabolism 2023;15(1):8-14.
DOI: https://doi.org/10.15747/ACNM.2023.15.1.8
Published online: April 1, 2023
1Department of Pharmacy, Seoul National University Hospital, Seoul, Korea
2Clinical Trials Center, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea
3College of Pharmacy, Wonkwang University, Iksan, Korea
- Corresponding author: Sook Hee An, email: shan7@wku.ac.kr
• Received: February 3, 2023 • Revised: March 9, 2023 • Accepted: March 13, 2023
© 2023 The Korean Society of Surgical Metabolism and Nutrition · The Korean Society for Parenteral and Enteral Nutrition
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
- 10 Views
- 0 Download
- Abstract
- Introduction
- Measuring selenium level and its normal range
- Selenium deficiency-related disease and symptoms
- Factors associated with selenium deficiency in infants
- Clinical outcomes associated with selenium level or supplementation
- Selenium supplementation through PN
- Selenium supplementation through oral or enteral nutrition
- Conclusion
- Acknowledgments
- Notes
- References
Abstract
-
Purpose This review aims to provide an overview of the factors and clinical outcomes associated with selenium deficiency and the guidelines on the optimal selenium supplementation in infants.
-
Current concept Selenium is a cofactor required to maintain the activity of glutathione peroxidase and is an essential trace element in the human body. Selenium is involved in many stages of oxidative injury within the human body. In severe cases, selenium deficiency may lead to cardiomyopathy. Particularly in infants, the risk factors for selenium deficiency are preterm birth and long-term parenteral nutrition. Several studies have been conducted on the relationship between selenium deficiency and bronchopulmonary dysplasia, retinopathy of prematurity, and sepsis, all of which are common diseases in preterm infants. In the past, 2–3 mcg/kg/day of intravenous selenium supplementation was recommended in preterm infants with selenium deficiency. However, recent studies have suggested that only 2–3 mcg/kg/day can prevent further decreases of selenium level in the blood of preterm infants, and that higher supplementation of 1.5–4.5 mcg/kg/day or 7 mcg/kg/day is necessary to reach the level of healthy infants at term. The recommended dose of selenium through enteral nutrition for preterm infants is 1.3–4.5 mcg/kg/day or 5–10 mcg/kg/day, depending on the guideline.
-
Conclusion Adequate selenium administration is required for adequate nutritional support in infants to prevent selenium deficiency, and more studies should be conducted to establish dosing guidelines considering risk factors in preterm infants.
Introduction
Selenium is an essential trace element and a component of various proteins such as selenium-dependent glutathione peroxidase, selenoprotein P, and iodothyronine-5’-deiodinase [1]. Selenium is a cofactor required to maintain the activity of glutathione peroxidase and plays an important role in anti-oxidative processes in the human body [2]. Selenoprotein P is an important factor in the regulation of reactive oxygen species and has influence on both inflammation and immunity [3]. Further, iodothyronine-5’-deiodinase converts thyroxine (T4) to triiodothyronine (T3), involving selenium is the process of thyroid function [4].
When selenium is deficient in the human body, symptoms such as macrocytosis and pseudoalbinism can appear; severe cases can experience cardiomyopathy, muscle fatigue, and Keshan disease [5,-8]. While cases of selenium excess are rare, its symptoms include nausea, diarrhea, hair loss, garlic-odor breath, and skin rash [9].
Selenium deficiency in infants most commonly occurs in preterm infants [10,11], in whom the storage capacity of selenium in the liver is limited compared to that of term infants. In addition, selenium is depleted quickly with rapid growth [12]. These factors can lead to low selenium level in the blood [13]. In addition, feeding intolerance is common in preterm infants due to limited gastric capacity, reduced gut mobility, and other factors. Therefore, there is a strong possibility of preterm infants with feeding intolerances becoming dependent on parenteral nutrition (PN) [1,14]. Selenium deficiency occurs more frequently with long-term PN that does not include selenium [15,16].
This review outlines the clinical issues associated with selenium deficiency and the guidelines on optimal selenium supplementation in infants.
Measuring selenium level and its normal range
Selenium level can be measured in whole blood, serum, plasma, urine, or hair. Alternatively, the activity of glutathione peroxidase in plasma or red blood cells can be used to measure selenium status. However, the activity of glutathione peroxidase is not a useful tool in preterm infants, as they are immature and might be influenced by exposure to supplemental oxygen [17].
Blood selenium level varies depending on the selenium concentration of the soil in each region, as well as personal eating habits. Some studies have reported plasma selenium concentrations of 50–150 mcg/L as the normal range in healthy infants and children, while others have reported 57–94 mcg/L as the normal range in infants at term [9,18]. One Korean study reported an average 57.6 mcg/L serum selenium level in infants 0–5 months old [19].
Serum selenium level is associated with age and increases with increasing age [20]. Preterm infants tend to show lower serum selenium level compared to term infants [21].
Selenium deficiency-related disease and symptoms
Selenium deficiency is often mentioned in association with a disease called Keshan disease and is the major cause of the disease. Patients with Keshan disease manifest congestive heart failure, acute heart failure, and cardiac arrhythmias, which can be life-threatening [8]. When Keshan disease first was identified in northeast China in the 1940s, the fatality rate was up to 80% [7].
Selenium deficiency is rare in healthy, well-fed infants but more common in patients receiving long-term PN [15]. Some cases with long-term PN have involved erythrocyte macrocytosis, loss of pigmentation of the hair and skin, and muscle weakness [5]. Low selenium concentration does not produce detectable clinical manifestation in all patients, complicating its diagnosis. However, it is important to prevent selenium deficiency because of its possibility to result in fatal symptoms [8].
Factors associated with selenium deficiency in infants
Fetal selenium storage begins at the third trimester of pregnancy, and preterm infants have less selenium stored in the liver compared to term infants [12]. Selenium level in umbilical cord blood has been correlated with gestational age and maternal selenium level. One study showed lower selenium level in the umbilical cord blood of preterm infants than that of term infants [22]. Similarly, many other studies have reported lower blood selenium level in preterm infants than term infants [10,11,23]. Another study showed more frequent selenium deficiency in extremely low birth weight infants and very low birth weight infants compared to normal birth weight infants [24].
The risk of selenium deficiency increases with long-term PN, as selenium is often not included in nutritional supplementation or included in insufficient amount. One study reported a significant decline in blood selenium level in low birth weight infants administered PN for one week [25]. Another study showed that preterm infants supplied with 88% of their total daily energy requirements through PN showed remarkable decrease in plasma serum selenium concentration [26]. Cases of growth retardation and pseudo-albinism accompanied by hair loss due to selenium deficiency have been reported in infants receiving long-term PN [27]. When selenium is mixed with a high concentration of ascorbic acid, a reduction reaction may result in precipitation of selenium, hindering selenium supplementation in short-term PN in certain cases [28]. As a result, selenium deficiency is more common in patients who receive selenium-free PN.
Clinical outcomes associated with selenium level or supplementation
Many studies are ongoing to discover the relationships between selenium deficiency and bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP), sepsis, and hypothyroidism, in which selenium plays an important role (Table 1).
BPD is a chronic lung disease that commonly occurs in preterm infants treated with oxygen for illnesses related to oxidative stress. One study reported lower plasma selenium concentration in preterm infants with BPD and an increase in duration of oxygen dependence by 58% when the plasma selenium level was lowered by 0.1 μM/L [29]. Another study reported that their BPD group had lower blood selenium level than the non-BPD group at 1 month after birth [30]. In addition, a prior study reported no significant differences in selenium level between infants with and without BPD at 1 month after birth; however, the selenium level in infants with BPD was lower than that of their first umbilical cord blood samples [31]. All of the studies mentioned above focused on the association of BPD and blood selenium level. Therefore, additional research is necessary to discover the cause-and-effect relationship between selenium deficiency and BPD.
ROP occurs when abnormal blood vessels grow in the retina and is more likely to occur in infants of younger gestational ages. One study reported that the concentration of selenium-dependent glutathione peroxidase was relatively higher in the retinas of preterm infants [32]. Similarly, one study reported that preterm infants with ROP showed much lower selenium serum level than normal term infants [33]. However, several other studies did not find any significant differences between groups with and without selenium supplementation [34,35]. More research is necessary to determine the relationship between ROP and selenium.
Previous studies were conducted under the assumption that sepsis is related to the antioxidant action and immune-related functions of selenium. One study reported that a group of infants given selenium supplementation had a lower incidence of sepsis at one week after birth compared to a placebo group [34]. Another study reported that a group of infants given intravenous selenium at 3 mcg/kg/day had much lower incidence of microbiologically confirmed cases of sepsis or sepsis requiring treatment with antibiotics for 5 days or more compared to the group who did not receive selenium [35]. Furthermore, a prior study reported that a group of preterm infants with very low birth weight who received daily oral supplementation of 10 mcg of selenium had lower incidence of sepsis confirmed by blood culture tests compared to a placebo group [36].
Selenium is known to be associated with thyroid function and is a component of iodothyronine deiodinase type 1, which converts T4 to T3. Selenium deficiency reduces the activity of selenoprotein glutathione peroxidase, which detoxifies hydrogen peroxide and prevents lipid peroxidation [37]. Oral supplementation of 50 mcg of selenium for 2 months in 52 healthy children led to significant reductions of the concentrations of T4, free T4, and reverse T3 in the serum [38]. However, one study on extremely low birth weight infants showed that more than half of infants with low serum selenium had normal free T4 concentration and observed no correlation between serum selenium level and hypothyroidism [10].
Selenium supplementation through PN
Guidelines on the adequate amount of selenium supplementation in infants through PN varies (Table 2). The American Society for Parenteral and Enteral Nutrition (ASPEN) recommends 1.5–2 mcg/kg/day of selenium for preterm neonates <3 kg and 2 mcg/kg/day of selenium for term neonates through PN [39]. Further, ASPEN suggested supplementing 1.5–4.5 mcg/kg/day for preterm infants [40]. The European Society for Clinical Nutrition and Metabolism (ESPEN)’s 2005 guideline recommended 2–3 mcg/kg/day of selenium supplementation for PN-dependent low birth weight infants [41]. However, this guideline was revised in 2018 and now recommends 2–3 mcg/kg/day of selenium supplementation for term infants, while the amount for preterm infants was increased to 7 mcg/kg/day [42]. The results of several studies led to this increase in recommended amount of selenium supplementation.
Previous studies have concluded that 2–3 mcg/kg/day of selenium supplementation is insufficient for newborns, especially for preterm newborns (Table 3). One study showed that supplementation of 3 mcg/kg/day of selenium for preterm infants through PN prevented selenium deficiency; however, it was insufficient to reach the level attained in breastfed term infants [35]. In another study, 29 extremely low birth weight infants were given 2 mcg/kg/day of selenium through PN, 26 of whom had serum selenium level lower than 57 mcg/L, which was defined as normal [10]. One United States study showed that almost all infants were selenium deficient when receiving 2 mcg/kg/day of selenium, and the proportion of infants with deficiencies was reduced when 6 mcg/kg/day or more of selenium was administered [43]. ESPEN cited a randomized clinical trial on 534 very low birth weight infants when it increased the recommended dose for selenium supplementation. That study showed meaningful increase in plasma selenium level compared to healthy term infants when 7 mcg/kg/day of selenium was supplemented [34]. That study was conducted in New Zealand, where the selenium level in soil is low, which leads to relatively low selenium levels in breast milk. All of these studies imply that the previously recommended selenium supplementation of 2–3 mcg/kg/day only prevents reduction of selenium level. Higher doses of selenium supplementation are necessary to improve blood selenium level.
Selenium supplementation through oral or enteral nutrition
Regional variability is seen with selenium consumption based on dietary intake. Selenium supplementation in infants fed with breast milk is estimated to be 2.5 mcg/kg/day with 80% bioavailability [41,44]. Selenium level in breast milk show regional variability and are reported to be associated with the selenium level in the soil of each region, as well as the mother’s selenium consumption [45]. Furthermore, an infant’s blood selenium level varies depending on whether it is fed with breast milk or infant formula. One study showed that term infants fed with breast milk had higher level of selenium than those fed with infant formula [13]. One German study reported that infants fed with breast milk maintained their plasma selenium level at birth until 4 months of age, while those fed with infant formula showed decrease in plasma selenium level [46]. In addition, that study reported that infants fed with hypoallergenic formula had lower selenium level compared to those fed with regular formula. The recommended supplementary dose of selenium varies among guidelines (Table 4). ASPEN recommends 1.3–4.5 mcg/kg/day of selenium to be supplemented through enteral nutrition for preterm infants [40,47]. The European Society for Paediatric Gastroenterology Hepatology and Nutrition 2010, in contrast, recommends 5–10 mcg/kg/day of selenium for preterm infants [48]. Recommendations for adequate selenium supplementation differ among regions and countries.
Conclusion
Selenium deficiency may be associated with oxidative injuries and diseases such as BPD and sepsis. Preterm infants and those given long-term PN are not only at risk of low baseline selenium level, but also of selenium deficiency secondary to insufficient supplementation. Therefore, infants’ clinical statuses and levels of selenium deficiency need to be considered when supplementing with appropriate amounts of selenium, and regular follow-up monitoring should be conducted. Future studies should consider multiple risk factors in order to optimize selenium dosing regimens for infants.
Acknowledgments
None.
Authors’ contribution
Conceptualization: JYL. Investigation: JYL, SHA. Methodology: JYL. Supervision: JYL, MJK, HJK, SYS, YSC, SHA. Writing – original draft: JYL, MJK. Writing – review & editing: JYL, MJK, HJK, SYS, YSC, SHA.
Conflict of interest
Sook Hee An is the Editor-in-Chief of the journal, but was not involved in the review process of this manuscript. Otherwise, there is no conflict of interest to declare.
Funding
This work was supported by a research grant from the Korean Society for Parenteral and Enteral Nutrition in 2020.
Data availability
None.
Supplementary materials
None
Table 1
Literature evaluation of selenium and relevant clinical outcomes
|
Relevant clinical outcome |
Study design |
Patients (or participants) |
Selenium supplementation | Results | Reference |
|---|---|---|---|---|---|
| BPD | Prospective observational | 79 infants with VLBW or GA ≤32 | - | Duration of oxygen dependence increased by 58% when the plasma selenium level was lowered by 0.1 μM/L | Darlow et al. [29] |
| Prospectiveobservational | 38 preterm infants with GA ≤32 | - | Serum selenium concentration was lower at 1 month after birth in patients with BPD (38.5±14.1 vs. 45.4±18.7 mcg/L, P=0.02) | Mostafa-Gharehbaghi et al. [30] | |
| Prospective observational | 54 preterm infants with GA ≤30 | - | No significant difference in selenium level between infants with and without BPD at 1 month after birth (P=0.40) | Peirovifar et al. [31] | |
| ROP | Prospective |
Observation group: 30 preterm infants who had high risk of ROP Control: 18 normal infants |
- | Preterm infants with ROP showed much lower level of serum selenium than normal infants at term (121.74±97.54 vs. 202.92±44.71 mcg/L, P<0.01) | Yang et al. [33] |
| RCT | 534 VLBW infants | 7 mcg/kg/day (PN) or 5 mcg/kg/day (oral) | No significant difference [relative risk 0.91 (0.69–1.21)] | Darlow et al. [34] | |
| RCT | 38 preterm infants | 3 mcg/kg/day (PN) | No significant difference | Daniels et al. [35] | |
| Sepsis | RCT | 534 VLBW infants | 7 mcg/kg/day (PN) or 5 mcg/kg/day (oral) | Fewer infants in the selenium group experienced nosocomial sepsis after the first week of life (25.1% vs. 33.3%, P=0.038) | Darlow et al. [34] |
| RCT | 38 preterm infants | 3 mcg/kg/day (PN) | Incidence of sepsis, defined as microbiologically confirmed or requiring antibiotics for at least 5 days, was greater in the PN without selenium group (79%, n=15 vs. 42%, n=8, P≤0.05) | Daniels et al. [35] | |
| RCT | 90 VLBW infants | 10 mcg/day (oral) | The total incidence of any LOS (i.e., culture-proven as well as probable sepsis) was significantly reduced by selenium supplementation [7/45 (15.55%) in selenium vs. 22/45 (48.88%) in placebo, P=0.001] | Aggarwal et al. [36] | |
| Hypothyroidism | Prospective | 29 ELBW infants | 2 mcg/kg/day (PN) | No significant correlation between serum selenium level and hypothyroidism | Klinger et al. [10] |
Table 2
Parenteral selenium daily recommendation (mcg/kg/day)
| Guideline |
ASPEN (2005) (Corkins et al. [39]) |
ASPEN position paper (2012) (Vanek et al. [40]) |
ESPEN (2005) [41] |
ESPEN (2018) (Domellöf et al. [42]) |
|---|---|---|---|---|
| Preterm infants | 1.5–2 | 1.5–4.5 |
2–3 (parenterally fed LBW infants) |
7 |
| Term infants | 2 | 2 | - | 2–3 |
Table 3
Literature evaluation of parenteral selenium supplementation
| Study design |
Patients (or participants) |
Selenium supplementation | Results | Reference |
|---|---|---|---|---|
| RCT | 38 preterm infants | 3 mcg/kg/day | Selenium supplementation prevented depletion | Daniels et al. [35] |
| Prospective | 29 ELBW infants | 2 mcg/kg/day | Twenty-six infants had serum selenium level lower than the normal 57 mcg/L | Klinger et al. [10] |
| Retrospective | 49 PN-dependent infants aged ≤1 year |
Shortage period: 2.1±1.2 mcg/kg/day Nonshortage period: 3.8±1 mcg/kg/day |
A linear relationship was observed between intravenous selenium dose and selenium level. At doses ≤2 mcg/kg/day, nearly 100% of infants were deficient (P<0.01); when doses ≥6 mcg/kg/day were provided, the incidence of selenium deficiency decreased | Chen et al. [43] |
| RCT | 534 VLBW infants | 7 mcg/kg/day (PN) or 5 mcg/kg/day (oral) | Mean plasma seleniume concentration at 28 days increased in the supplemented group (0.56 mcmol/L) but decreased in the control group (0.29 mcmol/L) (P<0.0001) | Darlow et al. [34] |
Table 4
Enteral selenium daily recommendation
| Guideline | Preterm infants | Term infants |
|---|---|---|
|
ASPEN position paper (2012) (Vanek et al. [40]) |
1.3–4.5 mcg/kg/day | 15 mcg/day |
|
ESPGHAN (2010) (Agostoni et al. [48]) |
5–10 mcg/kg/day | - |
- 1. Kleinman RE, Greer FR. Pediatric nutrition. 7th ed. American Academy of Pediatrics; 2013.
- 2. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 2007;9:775-806. ArticlePubMed
- 3. Hoffmann PR, Berry MJ. The influence of selenium on immune responses. Mol Nutr Food Res 2008;52:1273-80. ArticlePubMedPMC
- 4. Arthur JR, Nicol F, Beckett GJ. The role of selenium in thyroid hormone metabolism and effects of selenium deficiency on thyroid hormone and iodine metabolism. Biol Trace Elem Res 1992;34:321-5. ArticlePubMedPDF
- 5. Vinton NE, Dahlstrom KA, Strobel CT, Ament ME. Macrocytosis and pseudoalbinism: manifestations of selenium deficiency. J Pediatr 1987;111:711-7. ArticlePubMed
- 6. Ishida T, Himeno K, Torigoe Y, Inoue M, Wakisaka O, Tabuki T, et al. Selenium deficiency in a patient with Crohn's disease receiving long-term total parenteral nutrition. Intern Med 2003;42:154-7. ArticlePubMed
- 7. Chen J. An original discovery: selenium deficiency and Keshan disease (an endemic heart disease). Asia Pac J Clin Nutr 2012;21:320-6.PubMed
- 8. Shi Y, Yang W, Tang X, Yan Q, Cai X, Wu F. Keshan disease: a potentially fatal endemic cardiomyopathy in remote mountains of China. Front Pediatr 2021;9:576916. ArticlePubMedPMC
- 9. Litov RE, Combs GF Jr. 1991;Selenium in pediatric nutrition. Pediatrics 87:339-51. ArticlePubMedPDF
- 10. Klinger G, Shamir R, Singer P, Diamond EM, Josefsberg Z, Sirota L. Parenteral selenium supplementation in extremely low birth weight infants: inadequate dosage but no correlation with hypothyroidism. J Perinatol 1999;19(8 Pt 1):568-72. ArticlePubMedPDF
- 11. Freitas RGBON, Nogueira RJN, Hessel G. 2018;Selenium supplementation in pediatric patients using parenteral nutrition: is it time to do something? Rev Assoc Med Bras (1992) 64:217-23. ArticlePubMed
- 12. Bayliss PA, Buchanan BE, Hancock RG, Zlotkin SH. Tissue selenium accretion in premature and full-term human infants and children. Biol Trace Elem Res 1985;7:55-61. ArticlePubMedPDF
- 13. Sievers E, Arpe T, Schleyerbach U, Garbe-Schönberg D, Schaub J. Plasma selenium in preterm and term infants during the first 12 months of life. J Trace Elem Med Biol 2001;14:218-22. ArticlePubMed
- 14. Lucchini R, Bizzarri B, Giampietro S, De Curtis M. Feeding intolerance in preterm infants. How to understand the warning signs. J Matern Fetal Neonatal Med 2011;24 Suppl 1:72-4. ArticlePubMed
- 15. Kien CL, Ganther HE. Manifestations of chronic selenium deficiency in a child receiving total parenteral nutrition. Am J Clin Nutr 1983;37:319-28. ArticlePubMed
- 16. Marriott LD, Foote KD, Kimber AC, Delves HT, Morgan JB. Zinc, copper, selenium and manganese blood levels in preterm infants. Arch Dis Child Fetal Neonatal Ed 2007;92:F494-7. ArticlePubMedPMC
- 17. Daniels LA, Gibson RA, Simmer K. Glutathione peroxidase is not a functional marker of selenium status in the neonatal period. J Pediatr Gastroenterol Nutr 1998;26:263-8. ArticlePubMed
- 18. Finch CW. Review of trace mineral requirements for preterm infants: what are the current recommendations for clinical practice? Nutr Clin Pract 2015;30:44-58. PubMed
- 19. Kim HH, Yang HR, Kim HY. Selenium status and glutathione peroxidase activity in Korean infants. Korean J Nutr 2011;44:112-8. Article
- 20. Muntau AC, Streiter M, Kappler M, Röschinger W, Schmid I, Rehnert A, et al. Age-related reference values for serum selenium concentrations in infants and children. Clin Chem 2002;48:555-60. ArticlePubMedPDF
- 21. Amin S, Chen SY, Collipp PJ, Castro-Magana M, Maddaiah VT, Klein SW. Selenium in premature infants. Nutr Metab 1980;24:331-40. ArticlePubMedPDF
- 22. Bebars GM, Kamel BA, Allam E. Comparison between preterm and full term neonatal cord selenium in correlation to maternal serum selenium levels. Egypt Pediatr Assoc Gaz 2018;66:96-9. Article
- 23. Tsuzuki S, Morimoto N, Hosokawa S, Matsushita T. Associations of maternal and neonatal serum trace element concentrations with neonatal birth weight. PLoS One 2013;8:e75627. ArticlePubMedPMC
- 24. Rao A, Jericho H, Patton T, Sriram S, Hebert T, Weinstein D, et al. 2021;Factors affecting selenium status in infants on parenteral nutrition therapy. J Pediatr Gastroenterol Nutr 73:e73-8. ArticlePubMed
- 25. Huston RK, Benda GI, Carlson CV, Shearer TR, Reynolds JW, Neerhout RC. Selenium and vitamin E sufficiency in premature infants requiring total parenteral nutrition. JPEN J Parenter Enteral Nutr 1982;6:507-10. ArticlePubMed
- 26. Daniels L, Gibson R, Simmer K. Selenium status of preterm infants: the effect of postnatal age and method of feeding. Acta Paediatr 1997;86:281-8. ArticlePubMed
- 27. Masumoto K, Nagata K, Higashi M, Nakatsuji T, Uesugi T, Takahashi Y, et al. Clinical features of selenium deficiency in infants receiving long-term nutritional support. Nutrition 2007;23:782-7. ArticlePubMed
- 28. Allwood MC, Kearney MC. Compatibility and stability of additives in parenteral nutrition admixtures. Nutrition 1998;14:697-706. ArticlePubMed
- 29. Darlow BA, Inder TE, Graham PJ, Sluis KB, Malpas TJ, Taylor BJ, et al. The relationship of selenium status to respiratory outcome in the very low birth weight infant. Pediatrics 1995;96(2 Pt 1):314-9. ArticlePubMedPDF
- 30. Mostafa-Gharehbaghi M, Mostafa-Gharabaghi P, Ghanbari F, Abdolmohammad-Zadeh H, Sadeghi GH, Jouyban A. 2012;Determination of selenium in serum samples of preterm newborn infants with bronchopulmonary dysplasia using a validated hydride generation system. Biol Trace Elem Res 147:1-7. ArticlePubMedPDF
- 31. Peirovifar A, Gharehbaghi MM, Abdulmohammad-Zadeh H, Sadegi GH, Jouyban A. Serum selenium levels of the very low birth weight premature newborn infants with bronchopulmonary dysplasia. J Trace Elem Med Biol 2013;27:317-21. ArticlePubMed
- 32. Naash MI, Nielsen JC, Anderson RE. Regional distribution of glutathione peroxidase and glutathione-S-transferase in adult and premature human retinas. Invest Ophthalmol Vis Sci 1988;29:149-52.PubMed
- 33. Yang H, Ding Y, Chen L. Effect of trace elements on retinopathy of prematurity. J Huazhong Univ Sci Technolog Med Sci 2007;27:590-2. ArticlePubMedPDF
- 34. Darlow BA, Winterbourn CC, Inder TE, Graham PJ, Harding JE, Weston PJ, et al. The effect of selenium supplementation on outcome in very low birth weight infants: a randomized controlled trial. The New Zealand Neonatal Study Group. J Pediatr 2000;136:473-80. PubMed
- 35. Daniels L, Gibson R, Simmer K. Randomised clinical trial of parenteral selenium supplementation in preterm infants. Arch Dis Child Fetal Neonatal Ed 1996;74:F158-164. ArticlePubMedPMC
- 36. Aggarwal R, Gathwala G, Yadav S, Kumar P. Selenium supplementation for prevention of late-onset sepsis in very low birth weight preterm neonates. J Trop Pediatr 2016;62:185-93. ArticlePubMed
- 37. Duntas LH. Selenium and the thyroid: a close-knit connection. J Clin Endocrinol Metab 2010;95:5180-8. ArticlePubMed
- 38. Contempré B, Duale NL, Dumont JE, Ngo B, Diplock AT, Vanderpas J. Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clin Endocrinol (Oxf) 1992;36:579-83. ArticlePubMed
- 39. Corkins MR, Balint J, Bobo E, Plogsted S, Yaworski JA. The A.S.P.E.N. pediatric nutrition support core curriculum. 2nd ed. American Society for Parenteral and Enteral Nutrition; 2015.
- 40. Vanek VW, Borum P, Buchman A, Fessler TA, Howard L, Jeejeebhoy K, et al. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. Nutr Clin Pract 2012;27:440-91; Erratum in: Nutr Clin Pract 2014; 29:701. PubMed
- 41. 7. Iron, minerals and trace elements. J Pediatr Gastroenterol Nutr 2005;41:S39-46.
- 42. Domellöf M, Szitanyi P, Simchowitz V, Franz A, Mimouni F. ESPGHAN/ESPEN/ESPR/CSPEN Working Group on Pediatric Parenteral Nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: iron and trace minerals. Clin Nutr 2018;37(6 Pt B):2354-9. PubMed
- 43. Chen CH, Harris MB, Partipilo ML, Welch KB, Teitelbaum DH, Blackmer AB. 2016;Impact of the nationwide intravenous selenium product shortage on the development of selenium deficiency in infants dependent on long-term parenteral nutrition. JPEN J Parenter Enteral Nutr 40:851-9. ArticlePubMedPDF
- 44. Ehrenkranz RA, Gettner PA, Nelli CM, Sherwonit EA, Williams JE, Ting BT, et al. Selenium absorption and retention by very-low-birth-weight infants: studies with the extrinsic stable isotope tag 74Se. J Pediatr Gastroenterol Nutr 1991;13:125-33. ArticlePubMed
- 45. Dorea JG. Selenium and breast-feeding. Br J Nutr 2002;88:443-61. ArticlePubMed
- 46. Jochum F, Fuchs A, Menzel H, Lombeck I. Selenium in German infants fed breast milk or different formulas. Acta Paediatr 1995;84:859-62. ArticlePubMed
- 47. American Society for Parenteral and Enteral Nutrition (ASPEN). Enteral nutrition handbook. 2nd ed. ASPEN; 2005.
- 48. Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T, et al. ESPGHAN Committee on Nutrition. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr 2010;50:85-91. ArticlePubMed
References
Figure & Data
REFERENCES
Citations
Citations to this article as recorded by 
Cite
XML DownloadSelenium deficiency and supplementation in infants: a narrative review
Selenium deficiency and supplementation in infants: a narrative review
Literature evaluation of selenium and relevant clinical outcomes
| Relevant clinical outcome |
Study design |
Patients (or participants) |
Selenium supplementation | Results | Reference |
|---|---|---|---|---|---|
| BPD | Prospective observational | 79 infants with VLBW or GA ≤32 | - | Duration of oxygen dependence increased by 58% when the plasma selenium level was lowered by 0.1 μM/L | Darlow et al. [ |
| Prospectiveobservational | 38 preterm infants with GA ≤32 | - | Serum selenium concentration was lower at 1 month after birth in patients with BPD (38.5±14.1 vs. 45.4±18.7 mcg/L, P=0.02) | Mostafa-Gharehbaghi et al. [ |
|
| Prospective observational | 54 preterm infants with GA ≤30 | - | No significant difference in selenium level between infants with and without BPD at 1 month after birth (P=0.40) | Peirovifar et al. [ |
|
| ROP | Prospective | Observation group: 30 preterm infants who had high risk of ROP Control: 18 normal infants |
- | Preterm infants with ROP showed much lower level of serum selenium than normal infants at term (121.74±97.54 vs. 202.92±44.71 mcg/L, P<0.01) | Yang et al. [ |
| RCT | 534 VLBW infants | 7 mcg/kg/day (PN) or 5 mcg/kg/day (oral) | No significant difference [relative risk 0.91 (0.69–1.21)] | Darlow et al. [ |
|
| RCT | 38 preterm infants | 3 mcg/kg/day (PN) | No significant difference | Daniels et al. [ |
|
| Sepsis | RCT | 534 VLBW infants | 7 mcg/kg/day (PN) or 5 mcg/kg/day (oral) | Fewer infants in the selenium group experienced nosocomial sepsis after the first week of life (25.1% vs. 33.3%, P=0.038) | Darlow et al. [ |
| RCT | 38 preterm infants | 3 mcg/kg/day (PN) | Incidence of sepsis, defined as microbiologically confirmed or requiring antibiotics for at least 5 days, was greater in the PN without selenium group (79%, n=15 vs. 42%, n=8, P≤0.05) | Daniels et al. [ |
|
| RCT | 90 VLBW infants | 10 mcg/day (oral) | The total incidence of any LOS (i.e., culture-proven as well as probable sepsis) was significantly reduced by selenium supplementation [7/45 (15.55%) in selenium vs. 22/45 (48.88%) in placebo, P=0.001] | Aggarwal et al. [ |
|
| Hypothyroidism | Prospective | 29 ELBW infants | 2 mcg/kg/day (PN) | No significant correlation between serum selenium level and hypothyroidism | Klinger et al. [ |
BPD = bronchopulmonary dysplasia; ROP = retinopathy of prematurity; RCT = randomized clinical trial; VLBW = very low birth weight; GA = gestational age; ELBW = extremely low birth weight; PN = parenteral nutrition; LOS = late-onset sepsis.
Parenteral selenium daily recommendation (mcg/kg/day)
| Guideline | ASPEN (2005) (Corkins et al. [ |
ASPEN position paper (2012) (Vanek et al. [ |
ESPEN (2005) [ |
ESPEN (2018) (Domellöf et al. [ |
|---|---|---|---|---|
| Preterm infants | 1.5–2 | 1.5–4.5 | 2–3 (parenterally fed LBW infants) |
7 |
| Term infants | 2 | 2 | - | 2–3 |
ASPEN = American Society for Parenteral and Enteral Nutrition; ESPEN = European Society for Clinical Nutrition and Metabolism; LBW = low birth weight.
Literature evaluation of parenteral selenium supplementation
| Study design | Patients (or participants) |
Selenium supplementation | Results | Reference |
|---|---|---|---|---|
| RCT | 38 preterm infants | 3 mcg/kg/day | Selenium supplementation prevented depletion | Daniels et al. [ |
| Prospective | 29 ELBW infants | 2 mcg/kg/day | Twenty-six infants had serum selenium level lower than the normal 57 mcg/L | Klinger et al. [ |
| Retrospective | 49 PN-dependent infants aged ≤1 year | Shortage period: 2.1±1.2 mcg/kg/day Nonshortage period: 3.8±1 mcg/kg/day |
A linear relationship was observed between intravenous selenium dose and selenium level. At doses ≤2 mcg/kg/day, nearly 100% of infants were deficient (P<0.01); when doses ≥6 mcg/kg/day were provided, the incidence of selenium deficiency decreased | Chen et al. [ |
| RCT | 534 VLBW infants | 7 mcg/kg/day (PN) or 5 mcg/kg/day (oral) | Mean plasma seleniume concentration at 28 days increased in the supplemented group (0.56 mcmol/L) but decreased in the control group (0.29 mcmol/L) (P<0.0001) | Darlow et al. [ |
RCT = randomized clinical trial; ELBW = extremely low birth weight; PN = parenteral nutrition; VLBW = very low birth weight.
Enteral selenium daily recommendation
| Guideline | Preterm infants | Term infants |
|---|---|---|
| ASPEN position paper (2012) (Vanek et al. [ |
1.3–4.5 mcg/kg/day | 15 mcg/day |
| ESPGHAN (2010) (Agostoni et al. [ |
5–10 mcg/kg/day | - |
ASPEN = American Society for Parenteral and Enteral Nutrition; ESPGHAN = European Society for Paediatric Gastroenterology Hepatology and Nutrition.
Table 1
Literature evaluation of selenium and relevant clinical outcomes
BPD = bronchopulmonary dysplasia; ROP = retinopathy of prematurity; RCT = randomized clinical trial; VLBW = very low birth weight; GA = gestational age; ELBW = extremely low birth weight; PN = parenteral nutrition; LOS = late-onset sepsis.
Table 2
Parenteral selenium daily recommendation (mcg/kg/day)
ASPEN = American Society for Parenteral and Enteral Nutrition; ESPEN = European Society for Clinical Nutrition and Metabolism; LBW = low birth weight.
Table 3
Literature evaluation of parenteral selenium supplementation
RCT = randomized clinical trial; ELBW = extremely low birth weight; PN = parenteral nutrition; VLBW = very low birth weight.
Table 4
Enteral selenium daily recommendation
ASPEN = American Society for Parenteral and Enteral Nutrition; ESPGHAN = European Society for Paediatric Gastroenterology Hepatology and Nutrition.
